Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 47 | 2023 | 2758 | 4.950 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 8 | 2023 | 96 | 4.370 |
Why?
|
Radiography, Interventional | 9 | 2022 | 1095 | 2.740 |
Why?
|
Mammary Neoplasms, Experimental | 17 | 2018 | 520 | 2.670 |
Why?
|
Radiology, Interventional | 10 | 2022 | 460 | 2.570 |
Why?
|
Liver Neoplasms | 22 | 2024 | 4253 | 2.520 |
Why?
|
Ablation Techniques | 9 | 2021 | 249 | 2.440 |
Why?
|
Doxorubicin | 18 | 2016 | 2234 | 2.200 |
Why?
|
Chemoembolization, Therapeutic | 6 | 2023 | 129 | 2.010 |
Why?
|
Carcinoma, Hepatocellular | 16 | 2024 | 2214 | 1.920 |
Why?
|
Embolization, Therapeutic | 6 | 2021 | 1392 | 1.800 |
Why?
|
Cryosurgery | 4 | 2023 | 453 | 1.770 |
Why?
|
Antibiotics, Antineoplastic | 6 | 2016 | 692 | 1.690 |
Why?
|
Bile Duct Neoplasms | 4 | 2021 | 567 | 1.570 |
Why?
|
Hepatic Encephalopathy | 2 | 2022 | 139 | 1.500 |
Why?
|
Portal Vein | 6 | 2023 | 437 | 1.470 |
Why?
|
Venous Thrombosis | 6 | 2023 | 1239 | 1.440 |
Why?
|
Rats, Inbred F344 | 20 | 2024 | 862 | 1.440 |
Why?
|
Esophageal and Gastric Varices | 3 | 2023 | 207 | 1.420 |
Why?
|
Liver | 19 | 2022 | 7474 | 1.340 |
Why?
|
End Stage Liver Disease | 2 | 2022 | 314 | 1.140 |
Why?
|
Hyperthermia, Induced | 8 | 2016 | 403 | 1.130 |
Why?
|
Liver Transplantation | 4 | 2023 | 2119 | 1.120 |
Why?
|
Catheterization, Peripheral | 2 | 2020 | 345 | 1.110 |
Why?
|
Liposomes | 13 | 2023 | 759 | 1.030 |
Why?
|
Liver Neoplasms, Experimental | 5 | 2019 | 191 | 1.010 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 516 | 1.010 |
Why?
|
Hepatectomy | 2 | 2019 | 550 | 0.960 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2023 | 604 | 0.890 |
Why?
|
Surgery, Computer-Assisted | 5 | 2014 | 1018 | 0.830 |
Why?
|
Quercetin | 4 | 2016 | 93 | 0.780 |
Why?
|
Chemotherapy, Adjuvant | 13 | 2017 | 3479 | 0.780 |
Why?
|
Splenic Artery | 1 | 2021 | 54 | 0.770 |
Why?
|
Transurethral Resection of Prostate | 1 | 2021 | 83 | 0.750 |
Why?
|
Patient Readmission | 3 | 2020 | 3114 | 0.740 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 903 | 0.720 |
Why?
|
Electromagnetic Phenomena | 1 | 2020 | 161 | 0.710 |
Why?
|
Neoplasms | 14 | 2021 | 21683 | 0.710 |
Why?
|
Venereal Tumors, Veterinary | 3 | 2004 | 8 | 0.700 |
Why?
|
Splenic Vein | 1 | 2019 | 31 | 0.700 |
Why?
|
Hepatic Artery | 2 | 2018 | 245 | 0.700 |
Why?
|
Pericardiectomy | 1 | 2019 | 45 | 0.690 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 159 | 0.680 |
Why?
|
Hand | 2 | 2023 | 884 | 0.670 |
Why?
|
Radial Artery | 1 | 2020 | 194 | 0.670 |
Why?
|
Ultrasonography, Interventional | 6 | 2023 | 1486 | 0.640 |
Why?
|
Microwaves | 2 | 2016 | 191 | 0.630 |
Why?
|
Health Literacy | 1 | 2023 | 414 | 0.620 |
Why?
|
Drainage | 3 | 2022 | 1142 | 0.610 |
Why?
|
Motor Skills | 1 | 2020 | 522 | 0.600 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.600 |
Why?
|
Common Bile Duct Diseases | 1 | 2017 | 37 | 0.600 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2017 | 51 | 0.600 |
Why?
|
Adenocarcinoma | 9 | 2017 | 6364 | 0.590 |
Why?
|
Pericardial Effusion | 1 | 2019 | 247 | 0.590 |
Why?
|
Catheters | 2 | 2022 | 425 | 0.590 |
Why?
|
Heat-Shock Proteins | 4 | 2018 | 822 | 0.590 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 523 | 0.590 |
Why?
|
Terminology as Topic | 2 | 2014 | 1547 | 0.580 |
Why?
|
STAT3 Transcription Factor | 2 | 2019 | 873 | 0.580 |
Why?
|
HSP70 Heat-Shock Proteins | 3 | 2016 | 404 | 0.580 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.560 |
Why?
|
Ampulla of Vater | 1 | 2017 | 141 | 0.560 |
Why?
|
Nickel | 1 | 2017 | 130 | 0.560 |
Why?
|
Foot Diseases | 1 | 2017 | 143 | 0.560 |
Why?
|
Neoplasm Seeding | 1 | 2016 | 87 | 0.550 |
Why?
|
Fibroma | 1 | 2017 | 212 | 0.540 |
Why?
|
Nanoparticles | 3 | 2016 | 1905 | 0.540 |
Why?
|
Graft Occlusion, Vascular | 1 | 2018 | 549 | 0.510 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2023 | 1130 | 0.500 |
Why?
|
Sarcoma, Experimental | 2 | 2005 | 128 | 0.500 |
Why?
|
Rats | 22 | 2024 | 24260 | 0.500 |
Why?
|
Retrospective Studies | 39 | 2023 | 77449 | 0.490 |
Why?
|
Electric Conductivity | 6 | 2013 | 411 | 0.480 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 653 | 0.480 |
Why?
|
Telemedicine | 2 | 2022 | 2872 | 0.480 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 320 | 0.480 |
Why?
|
Kidney Neoplasms | 5 | 2019 | 4262 | 0.480 |
Why?
|
Hepatocyte Growth Factor | 4 | 2022 | 270 | 0.480 |
Why?
|
Postoperative Complications | 5 | 2021 | 15295 | 0.460 |
Why?
|
Angioplasty | 1 | 2016 | 364 | 0.450 |
Why?
|
Device Removal | 2 | 2023 | 656 | 0.440 |
Why?
|
Microvessels | 2 | 2017 | 544 | 0.440 |
Why?
|
Sulfones | 1 | 2015 | 437 | 0.440 |
Why?
|
Treatment Outcome | 28 | 2023 | 63114 | 0.430 |
Why?
|
Feasibility Studies | 5 | 2023 | 5078 | 0.430 |
Why?
|
Electroporation | 4 | 2016 | 251 | 0.430 |
Why?
|
Liver Diseases | 1 | 2021 | 1253 | 0.430 |
Why?
|
Pneumothorax | 3 | 2021 | 379 | 0.410 |
Why?
|
Clinical Competence | 5 | 2023 | 4687 | 0.410 |
Why?
|
Combined Modality Therapy | 16 | 2018 | 8642 | 0.400 |
Why?
|
Humans | 87 | 2023 | 744343 | 0.400 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 627 | 0.380 |
Why?
|
Micelles | 3 | 2016 | 203 | 0.370 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 93 | 0.370 |
Why?
|
Necrosis | 7 | 2022 | 1643 | 0.360 |
Why?
|
Middle Aged | 40 | 2023 | 213383 | 0.360 |
Why?
|
Boronic Acids | 1 | 2014 | 965 | 0.360 |
Why?
|
Thermal Conductivity | 2 | 2008 | 16 | 0.360 |
Why?
|
Female | 61 | 2024 | 380194 | 0.360 |
Why?
|
Male | 48 | 2023 | 350118 | 0.360 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 2161 | 0.350 |
Why?
|
Animals | 48 | 2024 | 168757 | 0.350 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3670 | 0.340 |
Why?
|
Neoplasm Transplantation | 7 | 2017 | 2085 | 0.340 |
Why?
|
Disease Models, Animal | 13 | 2023 | 18029 | 0.340 |
Why?
|
Up-Regulation | 2 | 2017 | 4217 | 0.340 |
Why?
|
Thrombosis | 1 | 2022 | 2968 | 0.330 |
Why?
|
Varicose Veins | 2 | 2023 | 154 | 0.330 |
Why?
|
Liver Diseases, Parasitic | 1 | 2008 | 10 | 0.330 |
Why?
|
Pyrazines | 1 | 2014 | 1230 | 0.320 |
Why?
|
Research Design | 2 | 2014 | 5987 | 0.320 |
Why?
|
Stents | 2 | 2018 | 3280 | 0.320 |
Why?
|
Liver Cirrhosis | 3 | 2022 | 1863 | 0.320 |
Why?
|
Physicians | 2 | 2023 | 4567 | 0.320 |
Why?
|
Internship and Residency | 3 | 2023 | 5788 | 0.320 |
Why?
|
Microspheres | 2 | 2021 | 777 | 0.320 |
Why?
|
Patient Care Planning | 1 | 2013 | 921 | 0.310 |
Why?
|
Schistosomiasis | 1 | 2008 | 62 | 0.310 |
Why?
|
Hypersensitivity | 1 | 2017 | 1102 | 0.310 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2022 | 3508 | 0.300 |
Why?
|
Heart Failure | 2 | 2022 | 10900 | 0.300 |
Why?
|
Antineoplastic Agents | 11 | 2015 | 13695 | 0.300 |
Why?
|
Splenic Diseases | 1 | 2008 | 94 | 0.300 |
Why?
|
Indoles | 1 | 2015 | 1839 | 0.290 |
Why?
|
Inflammation | 3 | 2016 | 10638 | 0.290 |
Why?
|
Tomography, Spiral Computed | 2 | 2005 | 280 | 0.280 |
Why?
|
Carcinoma, Renal Cell | 2 | 2019 | 3143 | 0.280 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3505 | 0.270 |
Why?
|
Mortality | 1 | 2017 | 2864 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9239 | 0.260 |
Why?
|
Saline Solution, Hypertonic | 2 | 2002 | 110 | 0.250 |
Why?
|
Soft Tissue Neoplasms | 2 | 2005 | 1363 | 0.250 |
Why?
|
Splenomegaly | 1 | 2005 | 190 | 0.250 |
Why?
|
Ambulatory Care | 3 | 2022 | 2708 | 0.240 |
Why?
|
Prostate | 2 | 2023 | 1774 | 0.240 |
Why?
|
Acetic Acid | 1 | 2003 | 55 | 0.230 |
Why?
|
Dog Diseases | 1 | 2003 | 138 | 0.220 |
Why?
|
Pelvis | 2 | 2023 | 730 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Granulocytes | 1 | 2023 | 548 | 0.200 |
Why?
|
Polyethylene Glycols | 4 | 2016 | 1182 | 0.200 |
Why?
|
Aged | 23 | 2023 | 163280 | 0.200 |
Why?
|
Suction | 1 | 2022 | 267 | 0.200 |
Why?
|
Hemostatic Techniques | 1 | 2002 | 116 | 0.200 |
Why?
|
Kidney | 5 | 2015 | 7186 | 0.190 |
Why?
|
Thrombectomy | 2 | 2023 | 680 | 0.190 |
Why?
|
Vena Cava Filters | 1 | 2023 | 252 | 0.190 |
Why?
|
Tonsillectomy | 2 | 2000 | 255 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11124 | 0.190 |
Why?
|
Myofibroblasts | 1 | 2022 | 222 | 0.190 |
Why?
|
Time Factors | 14 | 2023 | 40075 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 11 | 2023 | 20129 | 0.180 |
Why?
|
Subcutaneous Tissue | 2 | 2015 | 135 | 0.180 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 295 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
Electrocoagulation | 1 | 2000 | 158 | 0.180 |
Why?
|
Patient Satisfaction | 3 | 2023 | 3396 | 0.180 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2019 | 60 | 0.170 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 21827 | 0.170 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2023 | 450 | 0.170 |
Why?
|
Lymphatic Vessels | 1 | 2023 | 353 | 0.170 |
Why?
|
Punctures | 1 | 2020 | 374 | 0.170 |
Why?
|
Uterine Artery Embolization | 1 | 2019 | 62 | 0.170 |
Why?
|
Living Donors | 1 | 2023 | 620 | 0.170 |
Why?
|
Ascites | 2 | 2023 | 344 | 0.160 |
Why?
|
Peer Review, Health Care | 1 | 2019 | 75 | 0.160 |
Why?
|
Dissection | 1 | 2000 | 295 | 0.160 |
Why?
|
Cholangiography | 1 | 2019 | 189 | 0.160 |
Why?
|
Abscess | 1 | 2022 | 607 | 0.160 |
Why?
|
Employee Performance Appraisal | 1 | 2018 | 87 | 0.160 |
Why?
|
Hot Temperature | 5 | 2016 | 1354 | 0.160 |
Why?
|
Aminosalicylic Acids | 1 | 2017 | 37 | 0.160 |
Why?
|
Angiography | 1 | 2023 | 1639 | 0.150 |
Why?
|
Uterine Hemorrhage | 1 | 2019 | 255 | 0.150 |
Why?
|
Macrophages | 3 | 2023 | 5655 | 0.150 |
Why?
|
Neoplasm Metastasis | 3 | 2017 | 4851 | 0.150 |
Why?
|
Adult | 21 | 2023 | 214055 | 0.150 |
Why?
|
Abdomen | 1 | 2023 | 1118 | 0.150 |
Why?
|
Angiography, Digital Subtraction | 1 | 2018 | 341 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 35421 | 0.150 |
Why?
|
Length of Stay | 4 | 2018 | 6309 | 0.150 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 426 | 0.150 |
Why?
|
Patch Tests | 1 | 2017 | 53 | 0.150 |
Why?
|
Benzenesulfonates | 1 | 2017 | 169 | 0.140 |
Why?
|
Lymphedema | 1 | 2023 | 534 | 0.140 |
Why?
|
Radiation Dosage | 2 | 2021 | 1928 | 0.140 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2016 | 40 | 0.140 |
Why?
|
Breast Neoplasms | 2 | 2014 | 20822 | 0.140 |
Why?
|
Professional Practice | 1 | 2018 | 326 | 0.140 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1613 | 0.140 |
Why?
|
Arteries | 1 | 2021 | 1119 | 0.140 |
Why?
|
Societies, Medical | 3 | 2023 | 3743 | 0.140 |
Why?
|
Colorectal Neoplasms | 4 | 2023 | 6773 | 0.140 |
Why?
|
Interleukin-6 | 2 | 2016 | 3200 | 0.130 |
Why?
|
Vascular Patency | 1 | 2018 | 886 | 0.130 |
Why?
|
Equipment Failure Analysis | 2 | 2016 | 868 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 3557 | 0.130 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 258 | 0.130 |
Why?
|
Dogs | 4 | 2004 | 3912 | 0.130 |
Why?
|
Risk Factors | 11 | 2020 | 72290 | 0.130 |
Why?
|
Checklist | 1 | 2022 | 833 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1107 | 0.130 |
Why?
|
Teaching Rounds | 1 | 2019 | 253 | 0.130 |
Why?
|
Outpatients | 1 | 2022 | 1486 | 0.130 |
Why?
|
Syndrome | 1 | 2021 | 3251 | 0.120 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2016 | 162 | 0.120 |
Why?
|
Radiology Department, Hospital | 1 | 2018 | 412 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2019 | 1850 | 0.120 |
Why?
|
Vinblastine | 1 | 2016 | 502 | 0.120 |
Why?
|
Hypertrophy | 1 | 2016 | 569 | 0.120 |
Why?
|
Cholestasis | 1 | 2017 | 378 | 0.120 |
Why?
|
Radio Waves | 1 | 2015 | 251 | 0.120 |
Why?
|
Adrenalectomy | 1 | 2016 | 341 | 0.120 |
Why?
|
Hospital Mortality | 2 | 2018 | 5317 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 644 | 0.120 |
Why?
|
Analgesia, Epidural | 1 | 2017 | 327 | 0.120 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15540 | 0.120 |
Why?
|
Foot | 1 | 2017 | 527 | 0.120 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2494 | 0.120 |
Why?
|
Radiology Information Systems | 1 | 2018 | 523 | 0.110 |
Why?
|
Models, Anatomic | 1 | 2017 | 691 | 0.110 |
Why?
|
Oncogene Proteins | 1 | 2017 | 749 | 0.110 |
Why?
|
Fluoroscopy | 1 | 2017 | 924 | 0.110 |
Why?
|
Random Allocation | 2 | 2016 | 2429 | 0.110 |
Why?
|
Hyperaldosteronism | 1 | 2016 | 240 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2023 | 2278 | 0.110 |
Why?
|
Pancreaticoduodenectomy | 1 | 2016 | 503 | 0.110 |
Why?
|
Equipment Design | 4 | 2016 | 3582 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 413 | 0.110 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 608 | 0.110 |
Why?
|
Cell Proliferation | 3 | 2022 | 10481 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 514 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2023 | 2725 | 0.110 |
Why?
|
Mice | 8 | 2023 | 81183 | 0.100 |
Why?
|
Prospective Studies | 6 | 2021 | 53288 | 0.100 |
Why?
|
Models, Theoretical | 3 | 2019 | 3589 | 0.100 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 624 | 0.100 |
Why?
|
Electrodes | 3 | 2012 | 619 | 0.100 |
Why?
|
Documentation | 1 | 2018 | 871 | 0.100 |
Why?
|
Echocardiography | 2 | 2022 | 5102 | 0.100 |
Why?
|
Aldosterone | 1 | 2016 | 877 | 0.100 |
Why?
|
Computer Simulation | 4 | 2008 | 6196 | 0.100 |
Why?
|
Sarcoma | 1 | 2002 | 1897 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2728 | 0.090 |
Why?
|
Tumor Burden | 1 | 2016 | 1915 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2020 | 13102 | 0.090 |
Why?
|
Particle Size | 1 | 2014 | 1642 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
Ultrasonography | 1 | 2023 | 5985 | 0.090 |
Why?
|
Down-Regulation | 1 | 2017 | 3002 | 0.090 |
Why?
|
Medical History Taking | 1 | 2013 | 783 | 0.090 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4931 | 0.090 |
Why?
|
Cell Line, Tumor | 3 | 2016 | 16689 | 0.090 |
Why?
|
Learning | 1 | 2019 | 1713 | 0.090 |
Why?
|
Young Adult | 5 | 2022 | 56430 | 0.080 |
Why?
|
Stroke Volume | 1 | 2022 | 5007 | 0.080 |
Why?
|
Software | 1 | 2023 | 4443 | 0.080 |
Why?
|
Reoperation | 1 | 2018 | 4201 | 0.080 |
Why?
|
Students, Medical | 1 | 2021 | 1862 | 0.080 |
Why?
|
Pulmonary Blastoma | 1 | 2008 | 33 | 0.080 |
Why?
|
Swine | 7 | 2016 | 5917 | 0.080 |
Why?
|
Pilot Projects | 2 | 2020 | 8324 | 0.080 |
Why?
|
Boston | 2 | 2019 | 9313 | 0.080 |
Why?
|
Hepatocytes | 1 | 2015 | 1211 | 0.080 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3508 | 0.080 |
Why?
|
Lung | 3 | 2021 | 9856 | 0.080 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.080 |
Why?
|
Algorithms | 3 | 2023 | 13881 | 0.080 |
Why?
|
Graft Survival | 1 | 2018 | 3737 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19905 | 0.080 |
Why?
|
Pain Measurement | 1 | 2017 | 3420 | 0.080 |
Why?
|
Phantoms, Imaging | 2 | 2006 | 2480 | 0.080 |
Why?
|
Physical Examination | 1 | 2013 | 1237 | 0.080 |
Why?
|
Preoperative Care | 2 | 2013 | 2250 | 0.080 |
Why?
|
Injections, Intravenous | 3 | 2004 | 1420 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2942 | 0.070 |
Why?
|
Medical Oncology | 1 | 2019 | 2265 | 0.070 |
Why?
|
Perfusion | 2 | 2008 | 1360 | 0.070 |
Why?
|
Lymph Nodes | 2 | 2023 | 3474 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3752 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11366 | 0.070 |
Why?
|
Mentors | 2 | 2022 | 631 | 0.070 |
Why?
|
Mice, Nude | 1 | 2013 | 3689 | 0.070 |
Why?
|
Ethanol | 2 | 2003 | 1342 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2418 | 0.070 |
Why?
|
Phosphorylation | 1 | 2017 | 8436 | 0.070 |
Why?
|
Spinal Cord Injuries | 1 | 2014 | 931 | 0.070 |
Why?
|
Adenoma | 1 | 2016 | 2174 | 0.060 |
Why?
|
Quality Improvement | 2 | 2018 | 3749 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2635 | 0.060 |
Why?
|
Lumbar Vertebrae | 1 | 2014 | 1848 | 0.060 |
Why?
|
Injections, Intralesional | 1 | 2005 | 276 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 7799 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3843 | 0.060 |
Why?
|
Extracellular Fluid | 1 | 2005 | 167 | 0.060 |
Why?
|
Bronchography | 1 | 2003 | 74 | 0.060 |
Why?
|
Immunotherapy | 1 | 2019 | 4445 | 0.060 |
Why?
|
Regression Analysis | 3 | 2016 | 6459 | 0.060 |
Why?
|
Pleural Neoplasms | 1 | 2008 | 607 | 0.060 |
Why?
|
Lactates | 1 | 2024 | 432 | 0.060 |
Why?
|
Health Care Surveys | 2 | 2023 | 2453 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2024 | 200 | 0.060 |
Why?
|
Paclitaxel | 1 | 2010 | 1708 | 0.060 |
Why?
|
Lymphography | 1 | 2023 | 201 | 0.060 |
Why?
|
Prognosis | 2 | 2022 | 29063 | 0.060 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 32 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3507 | 0.050 |
Why?
|
Systems Analysis | 1 | 2023 | 172 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2023 | 224 | 0.050 |
Why?
|
Radiography | 2 | 2012 | 7023 | 0.050 |
Why?
|
Aged, 80 and over | 9 | 2017 | 57776 | 0.050 |
Why?
|
Lymphatic System | 1 | 2023 | 253 | 0.050 |
Why?
|
Observer Variation | 1 | 2008 | 2593 | 0.050 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2005 | 640 | 0.050 |
Why?
|
Rabbits | 2 | 2005 | 4894 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4215 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2004 | 625 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39050 | 0.050 |
Why?
|
Spectrometry, Fluorescence | 1 | 2003 | 689 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 2959 | 0.050 |
Why?
|
Drug Synergism | 1 | 2005 | 1792 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2005 | 2327 | 0.050 |
Why?
|
Temperature | 2 | 2006 | 2206 | 0.050 |
Why?
|
Absorptiometry, Photon | 1 | 2007 | 1725 | 0.050 |
Why?
|
Hospitalization | 2 | 2017 | 10262 | 0.050 |
Why?
|
Fluorouracil | 1 | 2005 | 1619 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2013 | 3528 | 0.050 |
Why?
|
Cyclosporine | 1 | 2003 | 786 | 0.050 |
Why?
|
Vena Cava, Inferior | 1 | 2023 | 440 | 0.050 |
Why?
|
Tonsillar Neoplasms | 1 | 2000 | 51 | 0.050 |
Why?
|
Administration, Cutaneous | 1 | 2002 | 711 | 0.050 |
Why?
|
Nanostructures | 1 | 2005 | 551 | 0.050 |
Why?
|
Ultrasonic Therapy | 1 | 2002 | 235 | 0.050 |
Why?
|
Anti-Infective Agents, Local | 1 | 2002 | 250 | 0.050 |
Why?
|
Palatine Tonsil | 1 | 2000 | 193 | 0.050 |
Why?
|
Chest Tubes | 1 | 2020 | 150 | 0.040 |
Why?
|
Dilatation and Curettage | 1 | 2019 | 56 | 0.040 |
Why?
|
Cisplatin | 1 | 2005 | 1662 | 0.040 |
Why?
|
Contrast Media | 3 | 2022 | 5300 | 0.040 |
Why?
|
Niacinamide | 1 | 2021 | 417 | 0.040 |
Why?
|
Hemoptysis | 1 | 2020 | 155 | 0.040 |
Why?
|
Pleura | 1 | 2020 | 235 | 0.040 |
Why?
|
Fever | 1 | 2006 | 1616 | 0.040 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2018 | 93 | 0.040 |
Why?
|
United States | 3 | 2023 | 69872 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 827 | 0.040 |
Why?
|
Forms and Records Control | 1 | 2019 | 160 | 0.040 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2003 | 721 | 0.040 |
Why?
|
Credentialing | 1 | 2018 | 126 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 528 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12245 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7659 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5686 | 0.040 |
Why?
|
Thorax | 1 | 2021 | 547 | 0.040 |
Why?
|
Risk Assessment | 3 | 2016 | 23338 | 0.040 |
Why?
|
Needles | 1 | 2020 | 449 | 0.040 |
Why?
|
Lactic Acid | 1 | 2022 | 1133 | 0.040 |
Why?
|
Feedback, Psychological | 1 | 2017 | 97 | 0.040 |
Why?
|
Clinical Coding | 1 | 2018 | 171 | 0.040 |
Why?
|
Sarcoma, Yoshida | 1 | 1986 | 11 | 0.040 |
Why?
|
Immunity | 1 | 2022 | 1012 | 0.040 |
Why?
|
Cattle | 2 | 2016 | 3922 | 0.030 |
Why?
|
Neuroendocrine Tumors | 1 | 2002 | 594 | 0.030 |
Why?
|
Agar | 2 | 2006 | 56 | 0.030 |
Why?
|
Polyethylene Terephthalates | 1 | 1986 | 116 | 0.030 |
Why?
|
Laser Therapy | 1 | 2002 | 1072 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2008 | 2400 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1917 | 0.030 |
Why?
|
Career Choice | 1 | 2021 | 744 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3309 | 0.030 |
Why?
|
Florida | 1 | 2016 | 435 | 0.030 |
Why?
|
Apoptosis | 4 | 2013 | 9727 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5952 | 0.030 |
Why?
|
Calcinosis | 1 | 2003 | 1499 | 0.030 |
Why?
|
Fertility | 1 | 2019 | 781 | 0.030 |
Why?
|
Trachea | 1 | 2020 | 1076 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1907 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11031 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6895 | 0.030 |
Why?
|
Abortion, Induced | 1 | 2019 | 458 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2018 | 643 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6538 | 0.030 |
Why?
|
Sulfur Hexafluoride | 1 | 2012 | 25 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2000 | 1381 | 0.030 |
Why?
|
Chronic Disease | 1 | 2008 | 9146 | 0.030 |
Why?
|
Triiodobenzoic Acids | 1 | 2012 | 124 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6365 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14722 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12959 | 0.030 |
Why?
|
Adolescent | 5 | 2016 | 85781 | 0.030 |
Why?
|
Iohexol | 1 | 2012 | 196 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9583 | 0.020 |
Why?
|
Phthalic Acids | 1 | 1986 | 436 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11524 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 610 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1265 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6386 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 4149 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3218 | 0.020 |
Why?
|
Deoxyguanosine | 1 | 2010 | 84 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13408 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Aldehydes | 1 | 2010 | 167 | 0.020 |
Why?
|
Phospholipids | 1 | 2012 | 784 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 601 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1177 | 0.020 |
Why?
|
Acetylcysteine | 1 | 2010 | 272 | 0.020 |
Why?
|
Thermography | 1 | 2008 | 67 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1827 | 0.020 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.020 |
Why?
|
Survival Rate | 2 | 2012 | 12788 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 8949 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 758 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2012 | 1641 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1799 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1831 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 7913 | 0.020 |
Why?
|
Nephrectomy | 1 | 2012 | 1050 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2046 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1100 | 0.020 |
Why?
|
Computer Graphics | 1 | 2008 | 361 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2008 | 431 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5882 | 0.020 |
Why?
|
Tyrosine | 1 | 2010 | 1461 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.020 |
Why?
|
Mass Screening | 1 | 2000 | 5255 | 0.020 |
Why?
|
Adrenergic Agonists | 1 | 2004 | 58 | 0.010 |
Why?
|
Halothane | 1 | 2004 | 206 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9849 | 0.010 |
Why?
|
Arsenicals | 1 | 2004 | 124 | 0.010 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2004 | 242 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.010 |
Why?
|
Calcium Oxalate | 1 | 2003 | 74 | 0.010 |
Why?
|
Durapatite | 1 | 2003 | 161 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 2 | 2008 | 4042 | 0.010 |
Why?
|
Oxides | 1 | 2004 | 405 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10252 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2759 | 0.010 |
Why?
|
Autoradiography | 1 | 2002 | 745 | 0.010 |
Why?
|
Surface-Active Agents | 1 | 2002 | 159 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 40561 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2008 | 1094 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
Tonsillitis | 1 | 2000 | 30 | 0.010 |
Why?
|
Child | 3 | 2012 | 77709 | 0.010 |
Why?
|
Pseudolymphoma | 1 | 2000 | 30 | 0.010 |
Why?
|
Child, Preschool | 2 | 2000 | 41006 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
Epinephrine | 1 | 2004 | 792 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2004 | 1525 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2432 | 0.010 |
Why?
|
Pakistan | 1 | 2000 | 295 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2376 | 0.010 |
Why?
|
Body Temperature Regulation | 1 | 2001 | 252 | 0.010 |
Why?
|
Histones | 1 | 2010 | 2599 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2007 | 1534 | 0.010 |
Why?
|
Anesthetics, Inhalation | 1 | 2004 | 570 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2010 | 3086 | 0.010 |
Why?
|
Body Composition | 1 | 2008 | 2401 | 0.010 |
Why?
|
Radiometry | 1 | 2003 | 800 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29144 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2274 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
Hypertension | 1 | 2016 | 8480 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13284 | 0.010 |
Why?
|
Models, Animal | 1 | 2002 | 2171 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 1413 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 21746 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6314 | 0.010 |
Why?
|
Carcinoma | 1 | 2004 | 2375 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 10943 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2000 | 5391 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.000 |
Why?
|
Infant | 1 | 2008 | 35136 | 0.000 |
Why?
|